{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:39:03Z","timestamp":1788489543552,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol. Sin."],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12250-021-00444-1","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T04:25:25Z","timestamp":1632803125000},"page":"1575-1584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation"],"prefix":"10.1016","volume":"36","author":[{"given":"Zhichao","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfa","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongzi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-0835","authenticated-orcid":false,"given":"Yingbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1638-6214","authenticated-orcid":false,"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"444_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/01.ANC.0000296631.80926.8d","volume":"7","author":"J Callen","year":"2007","unstructured":"Callen J, Paes BA (2007) A case report of a premature infant with coxsackie b1 meningitis. Adv Neonatal Care 7:238\u2013247","journal-title":"Adv Neonatal Care"},{"key":"444_CR2","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3892\/mmr.2015.3680","volume":"12","author":"L Cao","year":"2015","unstructured":"Cao L, Mao F, Pang Z, Yi Y, Qiu F, Tian R, Meng Q, Jia Z, Bi S (2015) Protective effect of enterovirus-71 (ev71) virus-like particle vaccine against lethal ev71 infection in a neonatal mouse model. Mol Med Rep 12:2473\u20132480","journal-title":"Mol Med Rep"},{"key":"444_CR3","first-page":"553","volume":"57","author":"CDC","year":"2008","unstructured":"CDC (2008) Increased detections and severe neonatal disease associated with coxsackievirus b1 infection\u2013united states, 2007. MMWR 57:553\u2013556","journal-title":"MMWR"},{"key":"444_CR4","first-page":"1577","volume":"59","author":"CDC","year":"2010","unstructured":"CDC (2010) Nonpolio enterovirus and human parechovirus surveillance\u2014united states, 2006\u20132008. MMWR 59:1577\u20131580","journal-title":"MMWR"},{"key":"444_CR5","first-page":"633","volume":"32","author":"W Chen","year":"2019","unstructured":"Chen W, Weng YW, Zhang YJ, He WX, Zhu Y, Yu TT, Xie JF, Zheng KC, Yan YS, Zhang WC (2019) Molecular epidemiology of coxsackievirus b1\u20135 associated with hfmd in fujian province, china, 2011\u20132016. Biomed Environ Sci 32:633\u2013638","journal-title":"Biomed Environ Sci"},{"key":"444_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/adc.64.3.404","volume":"64","author":"A Goren","year":"1989","unstructured":"Goren A, Kaplan M, Glaser J, Isacsohn M (1989) Chronic neonatal coxsackie myocarditis. Arch Dis Child 64:404\u2013406","journal-title":"Arch Dis Child"},{"key":"444_CR7","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1016\/j.vaccine.2017.05.057","volume":"35","author":"MM Hankaniemi","year":"2017","unstructured":"Hankaniemi MM, Laitinen OH, Stone VM, Sioofy-Khojine A, M\u00e4\u00e4tt\u00e4 JAE, Larsson PG, Marjom\u00e4ki V, Hy\u00f6ty H, Flodstr\u00f6m-Tullberg M, Hyt\u00f6nen VP (2017) Optimized production and purification of coxsackievirus b1 vaccine and its preclinical evaluation in a mouse model. Vaccine 35:3718\u20133725","journal-title":"Vaccine"},{"key":"444_CR8","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1016\/j.vaccine.2019.08.037","volume":"37","author":"MM Hankaniemi","year":"2019","unstructured":"Hankaniemi MM, Stone VM, Sioofy-Khojine AB, Heinim\u00e4ki S, Marjom\u00e4ki V, Hy\u00f6ty H, Blazevic V, Laitinen OH, Flodstr\u00f6m-Tullberg M, Hyt\u00f6nen VP (2019b) A comparative study of the effect of uv and formalin inactivation on the stability and immunogenicity of a coxsackievirus b1 vaccine. Vaccine 37:5962\u20135971","journal-title":"Vaccine"},{"key":"444_CR9","doi-asserted-by":"publisher","first-page":"104595","DOI":"10.1016\/j.antiviral.2019.104595","volume":"171","author":"MM Hankaniemi","year":"2019","unstructured":"Hankaniemi MM, Stone VM, Andrejeff T, Heinim\u00e4ki S, Sioofy-Khojine AB, Marjom\u00e4ki V, Hy\u00f6ty H, Blazevic V, Flodstr\u00f6m-Tullberg M, Hyt\u00f6nen VP, Laitinen OH (2019) Formalin treatment increases the stability and immunogenicity of coxsackievirus b1 vlp vaccine. Antivir Res 171:104595","journal-title":"Antivir Res"},{"key":"444_CR10","doi-asserted-by":"publisher","first-page":"7509","DOI":"10.1016\/j.vaccine.2019.09.072","volume":"37","author":"S Heinim\u00e4ki","year":"2019","unstructured":"Heinim\u00e4ki S, Hankaniemi MM, Sioofy-Khojine AB, Laitinen OH, Hy\u00f6ty H, Hyt\u00f6nen VP, Vesikari T, Blazevic V (2019) Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus. Vaccine 37:7509\u20137518","journal-title":"Vaccine"},{"key":"444_CR11","first-page":"1985","volume":"149","author":"M Hindersson","year":"2004","unstructured":"Hindersson M, Orn A, Harris RA, Frisk G (2004) Strains of coxsackie virus b4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance. Arch Virol 149:1985\u20132000","journal-title":"Arch Virol"},{"key":"444_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrendo.2017.184","volume":"14","author":"D Hober","year":"2018","unstructured":"Hober D, Alidjinou EK (2018) Diabetes: towards a coxsackievirus b-based vaccine to combat t1dm. Nat Rev Endocrinol 14:131\u2013132","journal-title":"Nat Rev Endocrinol"},{"key":"444_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12879-018-3659-7","volume":"19","author":"H Ji","year":"2019","unstructured":"Ji H, Fan H, Lu PX, Zhang XF, Ai J, Shi C, Huo X, Bao CJ, Shan J, Jin Y (2019) Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in jiangsu province: Epidemiology, etiology, and disease burden. BMC Infect Dis 19:79","journal-title":"BMC Infect Dis"},{"key":"444_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12985-017-0911-5","volume":"14","author":"Y Jin","year":"2017","unstructured":"Jin Y, Zhang C, Zhang R, Ren J, Chen S, Sui M, Zhou G, Dang D, Zhu J, Feng H, Xi Y, Yang H, Duan G (2017) Pulmonary edema following central nervous system lesions induced by a non- mouse-adapted ev71 strain in neonatal balb\/c mice. Virol J 14:243","journal-title":"Virol J"},{"key":"444_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/jmv.23359","volume":"85","author":"H Kim","year":"2013","unstructured":"Kim H, Kang B, Hwang S, Hong J, Chung J, Kim S, Jeong YS, Kim K, Cheon DS (2013) Molecular characteristics of human coxsackievirus b1 infection in korea, 2008\u20132009. J Med Virol 85:110\u2013115","journal-title":"J Med Virol"},{"key":"444_CR16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s00125-014-3436-0","volume":"58","author":"PG Larsson","year":"2015","unstructured":"Larsson PG, Lakshmikanth T, Laitinen OH, Utorova R, Jacobson S, Oikarinen M, Domsgen E, Koivunen MRL, Chaux P, Devard N, Lecouturier V, Almond J, Knip M, Hy\u00f6ty H, Flodstr\u00f6m-Tullberg M (2015) A preclinical study on the efficacy and safety of a new vaccine against coxsackievirus b1 reveals no risk for accelerated diabetes development in mouse models. Diabetologia 58:346\u2013354","journal-title":"Diabetologia"},{"key":"444_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.antiviral.2017.06.008","volume":"144","author":"S Li","year":"2017","unstructured":"Li S, Zhao H, Yang L, Hou W, Xu L, Wu Y, Wang W, Chen C, Wan J, Ye X, Liang Z, Mao Q, Cheng T, Xia N (2017) A neonatal mouse model of coxsackievirus a10 infection for anti-viral evaluation. Antivir Res 144:247\u2013255","journal-title":"Antivir Res"},{"key":"444_CR18","first-page":"1028","volume":"97","author":"JC Lu","year":"2005","unstructured":"Lu JC, Koay KW, Ramers CB, Milazzo AS (2005) Neonate with coxsackie b1 infection, cardiomyopathy and arrhythmias. J Natl Med Assoc 97:1028\u20131030","journal-title":"J Natl Med Assoc"},{"key":"444_CR19","doi-asserted-by":"publisher","first-page":"11967","DOI":"10.1128\/JVI.00902-12","volume":"86","author":"Q Mao","year":"2012","unstructured":"Mao Q, Wang Y, Gao R, Shao J, Yao X, Lang S, Wang C, Mao P, Liang Z, Wang J (2012) A neonatal mouse model of coxsackievirus a16 for vaccine evaluation. J Virol 86:11967\u201311976","journal-title":"J Virol"},{"key":"444_CR20","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2337\/db13-0620","volume":"63","author":"S Oikarinen","year":"2014","unstructured":"Oikarinen S, Tauriainen S, Hober D, Lucas B, Vazeou A, Sioofy-Khojine A, Bozas E, Muir P, Honkanen H, Ilonen J, Knip M, Keskinen P, Saha M-T, Huhtala H, Stanway G, Bartsocas C, Ludvigsson J, Taylor K, Hy\u00f6ty H (2014) Virus antibody survey in different european populations indicates risk association between coxsackievirus b1 and type 1 diabetes. Diabetes 63:655\u2013662","journal-title":"Diabetes"},{"key":"444_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrendo.2016.30","volume":"12","author":"A Op de Beeck","year":"2016","unstructured":"Op de Beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus\u2013why the \u03b2 cells? Nat Rev Endocrinol 12:263\u2013273","journal-title":"Nat Rev Endocrinol"},{"key":"444_CR22","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Hugo M (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27:493\u2013497","journal-title":"Am J Hyg"},{"key":"444_CR23","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00125-018-4561-y","volume":"61","author":"AB Sioofy-Khojine","year":"2018","unstructured":"Sioofy-Khojine AB, Lehtonen J, Nurminen N, Laitinen OH, Oikarinen S, Huhtala H, Pakkanen O, Ruokoranta T, Hankaniemi MM, Toppari J, V\u00e4h\u00e4-M\u00e4kil\u00e4 M, Ilonen J, Veijola R, Knip M, Hy\u00f6ty H (2018) Coxsackievirus b1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes. Diabetologia 61:1193\u20131202","journal-title":"Diabetologia"},{"key":"444_CR24","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.2337\/db10-0866","volume":"59","author":"LC Stene","year":"2010","unstructured":"Stene LC, Oikarinen S, Hy\u00f6ty H, Barriga KJ, Norris JM, Klingensmith G, Hutton JC, Erlich HA, Eisenbarth GS, Rewers M (2010) Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the diabetes and autoimmunity study in the young (daisy). Diabetes 59:3174\u20133180","journal-title":"Diabetes"},{"key":"444_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00125-017-4492-z","volume":"61","author":"VM Stone","year":"2018","unstructured":"Stone VM, Hankaniemi MM, Svedin E, Sioofy-Khojine A, Oikarinen S, Hy\u00f6ty H, Laitinen OH, Hyt\u00f6nen VP, Flodstr\u00f6m-Tullberg M (2018) A coxsackievirus b vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. Diabetologia 61:476\u2013481","journal-title":"Diabetologia"},{"key":"444_CR26","doi-asserted-by":"publisher","first-page":"eaaz2433","DOI":"10.1126\/sciadv.aaz2433","volume":"6","author":"VM Stone","year":"2020","unstructured":"Stone VM, Hankaniemi MM, Laitinen OH, Sioofy-Khojine AB, Lin A, Diaz Lozano IM, Mazur MA, Marjom\u00e4ki V, Lor\u00e9 K, Hy\u00f6ty H, Hyt\u00f6nen VP, Flodstr\u00f6m-Tullberg M (2020) A hexavalent coxsackievirus b vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates. Sci Adv 6:eaaz2433","journal-title":"Sci Adv"},{"key":"444_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/1096-9071(200009)62:1<70::AID-JMV11>3.0.CO;2-R","volume":"62","author":"S Tracy","year":"2000","unstructured":"Tracy S, H\u00f6fling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ (2000) Group b coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J Med Virol 62:70\u201381","journal-title":"J Med Virol"},{"key":"444_CR28","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1086\/605090","volume":"49","author":"ME Wikswo","year":"2009","unstructured":"Wikswo ME, Khetsuriani N, Fowlkes AL, Zheng X, Pe\u00f1aranda S, Verma N, Shulman ST, Sircar K, Robinson CC, Schmidt T, Schnurr D, Oberste MS (2009) Increased activity of coxsackievirus b1 strains associated with severe disease among young infants in the united states, 2007\u20132008. Clin Infect Dis 49:e44\u2013e51","journal-title":"Clin Infect Dis"},{"key":"444_CR29","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1086\/382598","volume":"189","author":"B Yanagawa","year":"2004","unstructured":"Yanagawa B, Spiller OB, Proctor DG, Choy J, Luo H, Zhang HM, Suarez A, Yang D, McManus BM (2004) Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice. J Infect Dis 189:1431\u20131439","journal-title":"J Infect Dis"},{"key":"444_CR30","doi-asserted-by":"publisher","first-page":"103490","DOI":"10.1016\/j.bioorg.2019.103490","volume":"95","author":"QX Zeng","year":"2020","unstructured":"Zeng QX, Wang HQ, Wei W, Guo TT, Yu L, Wang YX, Li YH, Song DQ (2020) Synthesis and biological evaluation of berberine derivatives as a new class of broad-spectrum antiviral agents against coxsackievirus b. Bioorg Chem 95:103490","journal-title":"Bioorg Chem"},{"key":"444_CR31","first-page":"e02450","volume":"91","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Dong Z, Wei Q, Carr MJ, Li J, Ding S, Tong Y, Li D, Shi W (2017) A neonatal murine model of coxsackievirus a6 infection for evaluation of antiviral and vaccine efficacy. J Virol 91:e02450\u2013e02416","journal-title":"J Virol"},{"key":"444_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/v10020058","volume":"10","author":"C Zhang","year":"2018","unstructured":"Zhang C, Zhang X, Dai W, Liu Q, Xiong P, Wang S, Geng L, Gong S, Huang Z (2018) A mouse model of enterovirus d68 infection for assessment of the efficacy of inactivated vaccine. Viruses 10:58","journal-title":"Viruses"},{"key":"444_CR33","doi-asserted-by":"publisher","first-page":"e85023","DOI":"10.1371\/journal.pone.0085023","volume":"8","author":"L Zhang","year":"2013","unstructured":"Zhang L, Yan J, Ojcius DM, Lv H, Miao Z, Chen Y, Zhang Y, Yan J (2013) Novel and predominant pathogen responsible for the enterovirus-associated encephalitis in eastern china. PloS One 8:e85023","journal-title":"PloS One"},{"key":"444_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.virusres.2008.04.012","volume":"135","author":"Z Zhong","year":"2008","unstructured":"Zhong Z, Li X, Zhao W, Tong L, Liu J, Wu S, Lin L, Zhang Z, Tian Y, Zhang F (2008) Mutations at nucleotides 573 and 579 within 5\u2019-untranslated region augment the virulence of coxsackievirus b1. Virus Res 135:255\u2013259","journal-title":"Virus Res"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-021-00444-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12250-021-00444-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-021-00444-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T01:37:51Z","timestamp":1641260271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12250-021-00444-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1007\/s12250-021-00444-1","relation":{},"ISSN":["1674-0769","1995-820X"],"issn-type":[{"value":"1674-0769","type":"print"},{"value":"1995-820X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"assertion":[{"value":"27 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All of the animal experiments in this study were approved by the Institutional Animal Care and Use Committee at Xiamen University and conducted in accordance with animal ethics guidelines and approved protocols.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal and Human Rights Statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}